دورية أكاديمية
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.
| العنوان: | Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. |
|---|---|
| المؤلفون: | Yimer, Habte, Melear, Jason, Faber, Edward, Bensinger, William, Burke, John M, Narang, Mohit, Stevens, Don, Gunawardena, Sriya, Lutska, Yana, Qi, Keqin, Ukropec, Jon, Qi, Ming, Lin, Thomas S, Rifkin, Robert M |
| المصدر: | Articles, Abstracts, and Reports |
| بيانات النشر: | Providence St. Joseph Health Digital Commons |
| سنة النشر: | 2019 |
| المجموعة: | Providence St. Joseph Health Digital Commons |
| مصطلحات موضوعية: | LYRA, bortezomib, cyclophosphamide, daratumumab, multiple myeloma, Hematology, Oncology |
| الوصف: | This United States community study evaluated the combination of daratumumab, bortezomib, cyclophosphamide and dexamethasone (D-VCd) in newly diagnosed multiple myeloma (NDMM) and relapsed multiple myeloma (RMM). Patients received 4-8 induction cycles of bortezomib 1·5 mg/m |
| نوع الوثيقة: | text |
| اللغة: | unknown |
| العلاقة: | https://digitalcommons.psjhealth.org/publications/1298Test; https://www.ncbi.nlm.nih.gov/pubmed/30828799Test |
| الإتاحة: | https://digitalcommons.psjhealth.org/publications/1298Test https://www.ncbi.nlm.nih.gov/pubmed/30828799Test |
| رقم الانضمام: | edsbas.BF60E18A |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |